Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Corboy, MD
University of Colorado, Denver
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
- University of Colorado Denver - Anschutz Medical Campus
Aurora, Colorado, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- University of Miami
Miami, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University St. Louis
St Louis, Missouri, United States
- Mt. Sinai University
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Virginia
Charlottesville, Virginia, United States
- Swedish Health Services
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2017
- Primary completion
- 31 Aug 2021
- Completion
- 31 Aug 2021
- Last update posted
- 16 Aug 2023
- Registered enrollment
- 259
- Registry id
- NCT03073603
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.